Kobayashi Pharmaceutical Co Ltd

Common Name

Kobayashi Pharmaceutical

Country

Japan

Sector

Consumer Defensive

Industry

Household & Personal Products

Employees

3,615

Ticker

4967

Exchange

TOKYO STOCK EXCHANGE

Website

www.kobayashi.co.jp

Description

Kobayashi Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, specializing in developing, manufacturing, and selling consumer health products. The company's portfolio includ... Show more

Financial Statements of Kobayashi Pharmaceutical

Below are the financial statements of Kobayashi Pharmaceutical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of JPY	2024	2023
Current assets	—	—
Cash and deposits	50,873^a	71,536^a
Notes and accounts receivable	49,442^a	53,028^a
Securities	14,872^a	8,300^a
Merchandise and finished goods	15,143^a	13,308^a
Work in process	2,091^a	1,767^a
Raw materials and supplies	6,929^a	7,006^a
Other	5,174^a	3,427^a
Allowance for doubtful accounts	-58^a	-44^a
Total current assets	144,468^a	158,331^a
Tangible fixed assets	—	—
Buildings and structures, net	32,461^a	10,611^a
Machinery, equipment and vehicles, net	6,476^a	5,152^a
Tools, furniture and fixtures, net	2,485^a	1,501^a
Land	5,947^a	4,900^a
Lease assets, net	815^a	964^a
Construction in progress	19,261^a	24,534^a
Total tangible fixed assets	67,448^a	47,665^a
Intangible assets	—	—
Goodwill	9,260^a	9,655^a
Trademarks	8,220^a	8,792^a
Software	2,662^a	2,664^a
Other	530^a	501^a
Fixed assets	—	—
Total intangible assets	20,674^a	21,614^a
Investments and other assets	—	—
Investment securities	24,617^a	32,124^a
Long-term loans receivable	1,269^a	1,132^a
Assets for retirement benefits	750^a	292^a
Deferred tax assets	3,087^a	2,647^a
Investment property, net	2,650^a	2,678^a
Other	1,730^a	2,163^a
Allowance for doubtful accounts	-1,328^a	-1,176^a
Total investments and other assets	32,777^a	39,862^a
Total fixed assets	120,900^a	109,142^a
Total assets	265,368^a	267,473^a
Current liabilities	—	—
Notes and accounts payable	8,264^a	8,745^a
Electronically recorded obligations	6,424^a	8,560^a
Accrued expenses	17,117^a	25,037^a
Lease liabilities	343^a	379^a
Income taxes payable	1,913^a	4,059^a
Consumption taxes payable	346^a	788^a
Provision for bonuses	2,840^a	2,705^a
Provision for product recall-related losses	3,970^a	0^a
Other	5,202^a	5,836^a
Total current liabilities	46,423^a	56,111^a
Non-current liabilities	—	—
Lease liabilities	503^a	608^a
Deferred tax liabilities	1,554^a	2,594^a
Liabilities for retirement benefits	1,005^a	939^a
Other	2,409^a	2,403^a
Total non-current liabilities	5,473^a	6,545^a
Total liabilities	51,896^a	62,656^a
Shareholders' equity	—	—
Capital stock	3,450^a	3,450^a
Capital surplus	522^a	522^a
Retained earnings	208,240^a	205,681^a
Treasury stock	-24,767^a	-24,766^a
Total shareholders' equity	187,445^a	184,887^a
Accumulated other comprehensive income	—	—
Valuation difference on available-for-sale securities	12,469^a	12,819^a
Foreign currency translation adjustments	12,300^a	6,403^a
Accumulated adjustments for retirement benefits	563^a	259^a
Total accumulated other comprehensive income	25,333^a	19,483^a
Net assets	—	—
Stock acquisition rights	688^a	446^a
Noncontrolling interests	4^a	0^a
Total net assets	213,471^a	204,816^a
Total liabilities and net assets	265,368^a	267,473^a

Download Data

Verified Sources Behind Kobayashi Pharmaceutical’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Kobayashi Pharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Kobayashi Pharmaceutical's Integrated Report 2025

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Kobayashi Pharmaceutical Co Ltd

Financial Statements of Kobayashi Pharmaceutical

Verified Sources Behind Kobayashi Pharmaceutical’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Rohto Pharmaceutical Co Ltd

Lion Corp

Unicharm Corp

NH Foods Ltd

Japan Tobacco Inc

Seven & i Holdings Co Ltd